News

Novo’s Ozempic linked to rare cases of serious eye disorder, EU regulator says
This is the first time a regulator has confirmed the side effect. Read more at straitstimes.com. Read more at ...
Novo Nordisk's Ozempic, Wegovy linked to rare cases of dangerous eye disorder, EMA says
The European Medicines Agency's safety committee has concluded that a potentially dangerous eye condition is a very rare side ...
MedPage Today on MSN2d
GLP-1 Drug Can Cause Rare, Potentially Blinding Side Effect, EMA Warns
A potentially blinding condition is a very rare side effect of the GLP-1 receptor agonist semaglutide (Ozempic, Wegovy, ...
TCTMD1d
Eye Condition a ‘Very Rare’ Side Effect of Semaglutide, EMA Says
Treatment should be stopped if nonarteritic anterior ischemic optic neuropathy, which can cause vision loss, is diagnosed.
BioSpace2d
EU Regulators Confirm Rare Vision Loss Risk for Novo’s Semaglutide
Given the evidence, the committee has recommended that the labels for Novo Nordisk’s Wegovy and Ozempic be updated to include ...
Novo Nordisk's Wegovy Tied To Increased Risk Of Rare Vision-Loss Disorder, European Regulators Say
The European Medicines Agency's (EMA) safety committee (PRAC) has concluded its review of medicines containing semaglutide ...
Medical Dialogues1d
EMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy
European Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide ...
Ozempic makes you twice as likely to develop this debilitating condition — what that really means for your risk
A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.
Novo Nordisk’s weight loss therapy linked to rare eye disorder, EU panel finds
Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...
EMA says Ozempic, Wegovy may cause rare eye condition
The European Medicines Agency’s (EMA) safety committee, PRAC, said Friday that it has concluded that Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION), a rare eye condition that can lead to ...
Novo's Ozempic, Wegovy linked to rare cases of dangerous eye disorder, EMA says
The European Medicines Agency's safety committee has concluded that the use of Novo Nordisk's popular weight-loss drug Wegovy ...